Search Login Register

Embryo Loss Summary

Description: Early pregnancy loss during the EMBRYO, MAMMALIAN stage of development. In the human, this period comprises the second through eighth week after fertilization.

Also Known As: Disintegration of Blastocyst; Disintegration of Embryo; Death, Embryo; Disintegration, Blastocyst; Embryo Deaths Show All >>

Networked: 130 relevant articles (7 outcomes, 11 trials/studies) for this Disease

Key Drugs and Agents for Embryo Loss

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Prostaglandins D (PGD) : 2 outcomes in 3 results : IBA
  2. Antigens : 1 outcome 1 study in 4 results : IBA
  3. Antibodies : 1 outcome 1 study in 3 results : IBA
  4. Immunoglobulin M (IgM) : 1 outcome 1 study in 2 results : IBA
  5. Freund's Adjuvant : 1 outcome 1 study in 1 result : IBA
  6. Acrolein (Aqualin) : 1 outcome in 2 results : IBA
  7. Putrescine : 1 outcome in 1 result : IBA
  8. Glutathione (Reduced Glutathione) : 1 outcome in 1 result : IBA
  9. lactate dehydrogenase C4 : 1 outcome in 1 result : IBA
  10. Nitric Oxide (Nitrogen Monoxide) : 2 studies in 6 results : FDA 1
Show All >>

Diseases Related to Embryo Loss

  1. Aneuploidy (Aneuploid)
  2. Hemorrhage
  3. Body Weight (Weight, Body)
  4. Spontaneous Abortion (Miscarriage)
  5. Fetal Weight
Show All >>

Key Therapies for Embryo Loss

Efficacy Chart >>
  1. Induced Abortion (Induced Abortions) : 1 outcome 1 study in 1 result
  2. Curettage : 1 outcome in 1 result
  3. Homologous Transplantation (Allograft) : 1 result
  4. Ovariectomy (Oophorectomy) : 1 result
  5. Laparotomy : 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.